These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 13889792)

  • 21. Metabolic effects of psychoactive drugs.
    SANKAR DV; GOLD E; SANKAR DB
    Recent Adv Biol Psychiatry; 1961; 4():247-56. PubMed ID: 14496953
    [No Abstract]   [Full Text] [Related]  

  • 22. A review of the neurophysiological effects of lysergic acid diethylamide (LSD) and other phychotomimetic agents.
    EVARTS EV
    Ann N Y Acad Sci; 1957 Mar; 66(3):479-95. PubMed ID: 13425237
    [No Abstract]   [Full Text] [Related]  

  • 23. [The effect of lysergic acid diethylamide (LSD-25) on the ERG of cold and warm blooded animals].
    MUELLER-LIMMROTH W; HARTMANN H
    Arch Int Pharmacodyn Ther; 1962 Jan; 135():57-67. PubMed ID: 14476956
    [No Abstract]   [Full Text] [Related]  

  • 24. [D-Lysergic acid diethylamide (LSD). 2. Clinical aspects].
    GROF S; VOJTECHOVSKY M; VOTAVA Z
    Lek Veda Zahr; 1960; 11():245-51 contd. PubMed ID: 13858660
    [No Abstract]   [Full Text] [Related]  

  • 25. Return of the lysergamides. Part II: Analytical and behavioural characterization of N
    Brandt SD; Kavanagh PV; Westphal F; Elliott SP; Wallach J; Colestock T; Burrow TE; Chapman SJ; Stratford A; Nichols DE; Halberstadt AL
    Drug Test Anal; 2017 Jan; 9(1):38-50. PubMed ID: 27265891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of D-lysergic acid diethylamide (LSD-25) on learning and retention.
    ARONSON H; WATERMANN CE; KLEE GD
    J Clin Exp Psychopathol Q Rev Psychiatry Neurol; 1962; 23():17-23. PubMed ID: 13862516
    [No Abstract]   [Full Text] [Related]  

  • 27. Hyperthermic effects of D-lysergic acid diethylamide (LSD) and its derivatives in rabbits and rats.
    Hashimoto H; Hayashi M; Nakahara Y; Niwaguchi T; Ishii H
    Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):314-21. PubMed ID: 303504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Placebo reactions in a study of lysergic acid diethylamide (LSD-25).
    LINTON HB; LANGS RJ
    Arch Gen Psychiatry; 1962 May; 6():369-83. PubMed ID: 14465662
    [No Abstract]   [Full Text] [Related]  

  • 29. Further studies of the effects of psychotropic drugs on the behavior of guinea pigs and rats.
    LIBERSON WT; ELLEN P; SCHWARTZ E; WILSON A; GAGNON VP
    J Neuropsychiatr; 1962; 3():298-303. PubMed ID: 14465046
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of lysergic acid diethylamide (LSD-25) on impulse control.
    ARONSON H; KLEE GD
    J Nerv Ment Dis; 1960 Dec; 131():536-9. PubMed ID: 13684462
    [No Abstract]   [Full Text] [Related]  

  • 31. Analeptic action of lysergic acid diethylamide (LSD-25) against pentobarbital.
    APTER JT
    AMA Arch Neurol Psychiatry; 1958 Jun; 79(6):711-5. PubMed ID: 13532082
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of LSD-25 upon the cerebral blood flow and EEG in cats.
    INGVAR DH; SODERBERG U
    Experientia; 1956 Nov; 12(11):427-9. PubMed ID: 13384405
    [No Abstract]   [Full Text] [Related]  

  • 33. [The effect of LSD on reaction times in a conditioned avoidance reaction and in the analgesia test].
    TAESCHLER M; WEIDMANN H; CERLETTI A
    Helv Physiol Pharmacol Acta; 1960; 18():43-9. PubMed ID: 13836568
    [No Abstract]   [Full Text] [Related]  

  • 34. The influence of varying dosage on the effects of lysergic acid diethylamide (LSD-25) in humans.
    KLEE GD; BERTINO J; WEINTRAUB W; CALLAWAY E
    J Nerv Ment Dis; 1961 May; 132():404-9. PubMed ID: 13756607
    [No Abstract]   [Full Text] [Related]  

  • 35. Unsurmountable antagonism of brain 5-hydroxytryptamine2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamide.
    Burris KD; Sanders-Bush E
    Mol Pharmacol; 1992 Nov; 42(5):826-30. PubMed ID: 1359397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proceedings: The effect of lysergic acid diethylamide (LSD) on the vas deferens and anococcygeus muscle.
    Gillespie JS; McGrath JC
    Br J Pharmacol; 1974 Sep; 52(1):128P. PubMed ID: 4451783
    [No Abstract]   [Full Text] [Related]  

  • 37. Changes in the liver protein pattern due to lysergic acid diethylamide (LSD).
    MISSERE G; TONINI G; BABBINI M
    Experientia; 1961 Jan; 17():33-4. PubMed ID: 13771306
    [No Abstract]   [Full Text] [Related]  

  • 38. Lysergic acid diethylamide (LSD-25). XXV. Effect of potassium cyanide and other oxidase and respiratory inhibitors on the Siamese fighting fish.
    WEISS B; ABRAMSON HA; BARON MO
    AMA Arch Neurol Psychiatry; 1958 Sep; 80(3):345-50. PubMed ID: 13570749
    [No Abstract]   [Full Text] [Related]  

  • 39. Drugs that antagonize limb flick behavior induced by D-lysergic acid diethylamide (LSD) in cats.
    Haigler HJ; Spring DD
    Psychopharmacology (Berl); 1979 Jun; 64(1):31-4. PubMed ID: 113828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lysergic acid diethylamide. Photoelectron ionization potentials as indices of behavioral activity.
    Domelsmith LN; Munchausen LL; Houk KN
    J Med Chem; 1977 Oct; 20(10):1346-8. PubMed ID: 903923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.